Author | David A. Braun, MD, PhD | OncLive

Author | David A. Braun, MD, PhD

Articles

Dr. Braun on Unanswered Questions With PD-1 Blockade in Advanced RCC

July 28, 2020

Video

David A. Braun, MD, PhD, discusses unanswered questions regarding the utility of PD-1 blockade in advanced renal cell carcinoma.

Dr. Braun on Frontline Immunotherapy in Advanced RCC

February 07, 2020

Video

David A. Braun, MD, PhD, physician at Dana-Farber Cancer Institute and instructor of medicine at Harvard Medical School, discusses the use of immunotherapy in the frontline treatment of patients with advanced renal cell carcinoma (RCC).

Dr. Braun on Evolution of Immunotherapy in Advanced Renal Cell Carcinoma

January 30, 2020

Video

David A. Braun, MD, PhD, discusses the evolution of immunotherapy in advanced renal cell carcinoma.

New Perioperative Strategies Emerge for High-Risk, Resectable RCC

December 04, 2019

Article

The current management of metastatic renal cell carcinoma reflects the progress of medical oncology throughout the past several decades. The standard of care has evolved from cytokine-based therapies to targeted molecular therapies and immune checkpoint inhibitor–based strategies.

x